Effect of Tranexamic Acid on Blood Loss After High Tibial Osteotomy

Osteoarthritis, Knee Clinical Trial

Official title: Effect of Tranexamic Acid on Blood Loss After High Tibial Osteotomy

Status Enrolling by invitation

Clinical Trial Summary

This study aims to examine whether tranexamic acid has an meaningful clinical effect on blood loss after high tibial osteotomy. This study design is a double-blind randomized controlled trial. The patients were randomly assigned to intervention or usual care groups. Intervention patients receive tranexamic acid 2g for 10 minutes just before surgery. Primary outcome is hemoglobin level preoperatively, postoperative 1 day, 2 days, 3 days, 2 weeks. Secondary outcome included hematocrit level, hemovac drainage, total blood loss, need for transfusion, deep vein thrombosis, Visual Analog Pain Scale, and wound complication.

Clinical Trial Description

High tibial osteotomy is proved treatment option for medial compartment osteoarthritis of knee joint. Especially, open wedge high tibial osteotomy might cause moderate amount of bleeding and hematoma formation. Bleeding and hematoma could be a reason of soft tissue infection and wound complications. Tranexamic acid (TXA) is a medication used to treat or prevent excessive blood loss from major trauma, postpartum bleeding, surgery, tooth removal, nosebleeds, and heavy menstruation. The objective of the study is to test whether preoperative tranexamic acid could reduce the postoperative complications due to bleeding. ;

Related Conditions & MeSH terms

• Osteoarthritis, Knee

• NCT number: NCT04653623
• Study type: Interventional
• Source: The Catholic University of Korea
• Status: Enrolling by invitation
• Phase: N/A
• Start date: October 1, 2019
• Completion date: December 31, 2020